Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2025-12-24 @ 3:00 PM
NCT ID:
NCT00835159
Eligibility Criteria:
Inclusion Criteria:
65 ≥ y.o. undergoing major elective surgery over 2 hours in length with one or more of the following:
* Preoperative cognitive impairment
* Age \> 70 y.o.
* Use of psychoactive medications
* History of prior delirium
* Severe illness/co-morbidity
Exclusion Criteria:
* Delirium on admission Profound dementia No spoken/written English An emergent procedure Hypersensitivity to Rivastigmine
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT00835159
Study Brief:
Protocol Section:
NCT00835159